C1 Esterase Inhibitor, Antigen
Electrolyte Panel, Serum
Adenovirus DNA, Real-time PCR, Qualitative
Anti-SARS-CoV-2 (Coronavirus), IgM
Small Lymphocytic Lymphoma, FISH
Warfarin Sensitivity (CYP2C9, CYP4F2, VKORC1)
Human Immunodeficiency Virus (HIV) Drug Resistance (GenoSure), NGS
Sodium, Random, Urine
Squamous Cell Carcinoma Antigen (SSCA)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Oncomine Dx (CDx) for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
Oncomine Dx (CDx) for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
Medical Test
Reference Ranges
Access to
Oncomine Dx (CDx) for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
is restricted.
Sign up now
Loading...